Does ANIDULAFUNGIN Cause Disease progression? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Disease progression have been filed in association with ANIDULAFUNGIN (ERAXIS). This represents 1.4% of all adverse event reports for ANIDULAFUNGIN.
10
Reports of Disease progression with ANIDULAFUNGIN
1.4%
of all ANIDULAFUNGIN reports
8
Deaths
6
Hospitalizations
How Dangerous Is Disease progression From ANIDULAFUNGIN?
Of the 10 reports, 8 (80.0%) resulted in death, 6 (60.0%) required hospitalization, and 2 (20.0%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANIDULAFUNGIN. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does ANIDULAFUNGIN Cause?
Drug ineffective (234)
Multiple organ dysfunction syndrome (108)
Off label use (85)
Candida infection (61)
Death (57)
Neutropenia (53)
Pneumonia (49)
Septic shock (45)
Sepsis (42)
Condition aggravated (37)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which ANIDULAFUNGIN Alternatives Have Lower Disease progression Risk?
ANIDULAFUNGIN vs ANIFROLUMAB
ANIDULAFUNGIN vs ANIFROLUMAB-FNIA
ANIDULAFUNGIN vs ANTHOXANTHUM ODORATUM POLLEN\DACTYLIS GLOMERATA POLLEN\LOLIUM PERENNE POLLEN\PHLEUM PRATENSE POLLEN\POA PRATENSIS POLLEN
ANIDULAFUNGIN vs ANTI-INHIBITOR COAGULANT COMPLEX
ANIDULAFUNGIN vs ANTIHEMOPHILIC FACTOR HUMAN